• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Eyenovia partners with Eversana to commercialize pupil dilation agent

March 23, 2021 By Sean Whooley

Eyenovia EversanaEyenovia (NSDQ:EYEN) announced today that it partnered with Eversana to help commercialize MydCombi if it earns U.S. approval.

MydCombi is a fixed-combination mydriatic agent for potential use in comprehensive eye exams with a formulation for touchless fixed-combination microdosing in an effort to improve the patient experience. The FDA earlier this month accepted Eyenovia’s New Drug Application for MydCombi.

The therapeutic is delivered through Eyenovia’s proprietary Optejet dispenser, which ensures consistent and easy application of two mydriatic medications in a quick, touchless micro-mist form. Optejet is designed with no protruding parts to prevent the accidental touching of the ocular surface.

Eyenovia said MydCombi, if approved by the FDA, would be the first microdosed ocular therapeutic applied with a high-precision smart delivery system. The company anticipates the potential approval to come in the fourth quarter of this year.

Under the commercialization agreement, Eversana will serve as Eyenovia’s exclusive distributor for all customers in the U.S., with responsibilities centered around accepting and managing orders, payments and the shipping of MydCombi to eye care offices throughout the U.S., according to a news release.

Eversana is also slated to establish an Eyenovia e-commerce platform to collect and analyze sales data and provide relevant analytics that will influence Eyenovia’s commercial strategy.

“Eyenovia is striving to make the MydCombi launch efficient and seamless for its eye care provider customers,” Eyenovia COO Michael Rowe said in the release. “Eversana has an exemplary track record for customer service and commercial excellence. Through this partnership, launch and distribution activities that would typically require an infrastructure build will be managed by Eversana, a strategy we anticipate will keep costs well below what is typical in ophthalmology.”

“We believe in MydCombi’s potential to provide patients clinical benefits and a more comfortable experience during eye exams,” Eversana CEO Jim Lang added. “With this collaboration, we look forward to contributing our expertise for a successful launch and roll-out of this valuable product to Eyenovia’s customers.”

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Optical/Ophthalmic Tagged With: Eversana, Eyenovia Inc.

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS